Plasma exosome proteomics reveals the pathogenesis mechanism of post-stroke cognitive impairment
Aging · 31.05.2023 · 15 (10) · 4334-4362
DOI: 10.18632/aging.204738 ↗Kurz gefasst
Fachartikel in der Zeitschrift Aging, online erschienen am 20.05.2023. Verfasst von Baoyun Qi und 6 weiteren Autor:innen. Beteiligte Einrichtung: The Eastern Area, Dongzhimen Hospital, Beijing University of Chinese Medicine, Beijing 101121, China. Hauptthemen laut MEDLINE: Exosomes, Cognitive Dysfunction, Stroke. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 32 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Themen: Schlaganfall
Abstract (Originalsprache)
Exploration and utilization of exosome biomarkers and their related functions provide the possibility for the diagnosis and treatment of post-stroke cognitive impairment (PSCI). To identify the new diagnostic and prognostic biomarkers of plasma exosome were uzed label-free quantitative proteomics and biological information analysis in PSCI patients. Behavioral assessments were performed, including the Mini-Mental Status Examination (MMSE), the Montreal Cognitive Assessment (MoCA), the Barthel index, the Morse Fall Seale (MFS) between control group (n = 10) and PSCI group (n = 10). The blood samples were collected to analyse the biomarker and differentially expressed proteins of plasma exosome using label-free quantitative proteomics and biological information. The exosomes marker proteins were determined by Western blot. The exosome morphology was observed by transmission electron microscopy. The scores of MMSE and MoCA were significantly decreased in the PSCI group. The PT% and high-density lipoprotein decreased and the INR ratio increased in PSCI group. The mean size of exosome was approximately 71.6 nm and the concentration was approximately 6.8E+7 particles/mL. Exosome proteomics identified 259 differentially expressed proteins. The mechanisms of cognitive impairment are related to regulate the degradation of ubiquitinated proteins, calcium dependent protein binding, cell adhesive protein binding, formation of fibrin clot, lipid metabolism and ATP-dependent degradation of ubiquitinated proteins in plasma exosome of PSCI patients. Plasma levels of YWHAZ and BAIAP2 were significantly increased while that of IGHD, ABCB6 and HSPD1 were significantly decreased in PSCI patients. These proteins might be target-related proteins and provide global insights into pathogenesis mechanisms of PSCI at plasma exosome proteins level.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- The Eastern Area, Dongzhimen Hospital, Beijing University of Chinese Medicine, Beijing 101121, China.
- Department of Neurology, Dongzhimen Hospital, Beijing University of Chinese Medicine, Beijing 100700, China.
- Institute for Brain Disorders, Beijing University of Chinese Medicine, Beijing 100013, China.
- Institute of Basic Research in Clinical Medicine, China Academy of Chinese Medical Sciences, Beijing 100700, China.
- Department of Neurology, Hohhot Mongolian Medicine of Traditional Chinese Medicine Hospital, Hohhot 010020, China.
- Institute of Information on Traditional Chinese Medicine, China Academy of Chinese Medical Sciences, Beijing 100700, China.
Zitieren
APA
Qi, B., Kong, L., Lai, X., Wang, L., Liu, F., Ji, W., & Wei, D. (2023). Plasma exosome proteomics reveals the pathogenesis mechanism of post-stroke cognitive impairment. Aging, 15(10), 4334-4362. https://doi.org/10.18632/aging.204738
Vancouver
Qi B, Kong L, Lai X, Wang L, Liu F, Ji W, et al. Plasma exosome proteomics reveals the pathogenesis mechanism of post-stroke cognitive impairment. Aging. 2023;15(10):4334-4362. doi:10.18632/aging.204738
BibTeX
@article{Qi2023,
author = {Qi, Baoyun and Kong, Lingbo and Lai, Xinxing and Wang, Linshuang and Liu, Fei and Ji, Weiwei and Wei, Dongfeng},
title = {Plasma exosome proteomics reveals the pathogenesis mechanism of post-stroke cognitive impairment},
journal = {Aging},
year = {2023},
volume = {15},
number = {10},
pages = {4334--4362},
doi = {10.18632/aging.204738}
}
EUVIMED